Omega Healthcare Investors, Inc. (NYSE:OHI) Shares Acquired by Johnson Investment Counsel Inc.

Johnson Investment Counsel Inc. lifted its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 10.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,017 shares of the real estate investment trust’s stock after buying an additional 1,129 shares during the period. Johnson Investment Counsel Inc.’s holdings in Omega Healthcare Investors were worth $412,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in OHI. Versant Capital Management Inc acquired a new stake in shares of Omega Healthcare Investors during the second quarter worth $26,000. WFA Asset Management Corp acquired a new position in Omega Healthcare Investors during the first quarter valued at $39,000. Covestor Ltd lifted its position in Omega Healthcare Investors by 47.6% during the first quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock valued at $42,000 after purchasing an additional 431 shares during the period. Highlander Capital Management LLC lifted its position in Omega Healthcare Investors by 52.0% during the first quarter. Highlander Capital Management LLC now owns 1,900 shares of the real estate investment trust’s stock valued at $60,000 after purchasing an additional 650 shares during the period. Finally, GAMMA Investing LLC lifted its position in Omega Healthcare Investors by 93.4% during the second quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust’s stock valued at $84,000 after purchasing an additional 1,181 shares during the period. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Up 0.1 %

Shares of NYSE OHI opened at $40.62 on Friday. Omega Healthcare Investors, Inc. has a 12-month low of $27.53 and a 12-month high of $40.99. The stock has a market cap of $10.47 billion, a PE ratio of 36.59, a P/E/G ratio of 1.48 and a beta of 1.00. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. The company has a 50-day moving average of $37.55 and a 200 day moving average of $33.63.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). The firm had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business’s revenue for the quarter was up 17.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.74 earnings per share. As a group, sell-side analysts predict that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Monday, August 5th were issued a $0.67 dividend. The ex-dividend date was Monday, August 5th. This represents a $2.68 annualized dividend and a yield of 6.60%. Omega Healthcare Investors’s payout ratio is 241.44%.

Wall Street Analysts Forecast Growth

OHI has been the subject of a number of research reports. Scotiabank boosted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. Wells Fargo & Company raised shares of Omega Healthcare Investors to a “strong-buy” rating in a report on Friday, June 14th. Truist Financial boosted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Finally, Mizuho cut shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their target price for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Eight equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $34.82.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.